Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease

BACKGROUND: Guidelines regarding the use of infliximab in Crohn’s disease were previously published by the Canadian Association of Gastroenterology in 2004. However, recent clinical findings and drug developments warrant a review and update of these guidelines.

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Daniel C Sadowski, Charles N Bernstein, Alain Bitton, Ken Croitoru, Richard N Fedorak, Anne Griffiths, the CAG Crohn’s Consensus Group
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Wiley 2009-01-01
Σειρά:	Canadian Journal of Gastroenterology
Διαθέσιμο Online:	http://dx.doi.org/10.1155/2009/201430
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!